New Key Statistics Module, Z-Score and F-Score
OTCPK:ALPMY Key Ratios
| Market Cap $ M | 17,267.55 |
| Enterprise Value $ M | 20,971.30 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.81 |
| Price/Sales | 1.74 |
| Price/Free Cash Flow | 22.03 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 10,885.00 |
| EPS (TTM) $ | -0.008 |
| Beneish M-Score | -2.84 |
| 10-y EBITDA Growth Rate % | 5.50 |
| 5-y EBITDA Growth Rate % | -3.30 |
| y-y EBITDA Growth Rate % | -40.80 |
| EV-to-EBIT | 105.20 |
| EV-to-EBITDA | 18.62 |
| PEG | -- |
| Shares Outstanding M | 1,793.10 |
| Net Margin (%) | -- |
| Operating Margin % | 0.81 |
| Pre-tax Margin (%) | 1.40 |
| Quick Ratio | 0.71 |
| Current Ratio | 0.91 |
| ROA % (ttm) | -- |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -- |
| Dividend Yield % | 4.70 |
| Altman Z-Score | 1.67 |
ALPMY Number of Guru Trades
ALPMY Volume of Guru Trades
Gurus Latest Trades with OTCPK:ALPMY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ALPMY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Astellas Pharma Inc Insider Transactions
No Available Data
News about OTCPK:ALPMY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers